surmount-1 tirzepatide weight loss nondiabetic for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Tirzepatide after intensive lifestyle intervention

Most patients benefit from a long-term maintenance strategy to prevent weight regain and protect metabolic health

Important Safety Information

What is Felix

In summary, tirzepatide was associated with greater and faster weight loss, lower adverse event prevalence, and larger reductions in multiple disease burdens compared with semaglutide, while both agents produced meaningful improvements across metabolic, respiratory, and neuropsychiatric domains

By understanding what to expect and how to manage muscle cramps, you can navigate this potential side effect while maximising the benefits of your Mounjaro treatment

Reuptake inhibition